Business
Tier 1 Pharmaceutical Manufacturer Selects Kneat's SaaS platform
Tier 1 Pharmaceutical Manufacturer Selects Kneat's SaaS platform Canada NewsWire ...
About this update from Kneat.com, Inc.
[{"type":"text","content":"\n\n\n\nTier 1 Pharmaceutical Manufacturer Selects Kneat's SaaS platform\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nHALIFAX, Feb. 15, 2018\n\n\n\nHALIFAX, Feb. 15, 2018 /CNW/ - kneat.com, inc. (TSX-V: KSI) (\"kneat.com\", \"Kneat\", or the \"Company\") is pleased to announce that a leading Tier 1 pharmaceutical company, headquartered in the United States and with over thirty manufacturing and laboratory sites globally, has selected Kneat. Kneat's software platform will replace the client's paper-based commissioning and qualification (\"C&Q\") process with one that is end-to-end paperless. Our new client is seeking to improve data integrity and productivity by implementing a structured C&Q process that can be leveraged globally across all sites. The desired outcome is to enable: \n\n\nusers to be more compliant and productive in real-time as they perform their work;\nmanagers full central visibility and control across all projects and systems; and\nsenior management to enhance compliance and drive down operational and capital costs.\nThe initial deployment is for C&Q at the client's headquartered manufacturing site in the United States, with deployment commencing immediately on Kneat's Software as a Service ('SaaS') platform.\n\n\"We are proud that this multinational pharmaceutical company recognizes the benefits of our software and we look forward to deployment in the near future.\"  said Eddie Ryan, CEO of Kneat.   \n\nKneat continues to expand its customer pipeline and will report on further developments as they occur.\n\nAbout Kneat\n\nKneat, develops and markets the next generation Kneat Gx software platform. Multiple business processes can be configured on the platform from equipment to computer system validation, through to production record execution and quality document management. Kneat Gx allows users to author, review, approve, execute testing online, manage any exceptions and post approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant plat...